These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9043561)

  • 1. Cost savings and avoidance from clinical interventions.
    Mutnick AH; Sterba KJ; Peroutka JA; Sloan NE; Beltz EA; Sorenson MK
    Am J Health Syst Pharm; 1997 Feb; 54(4):392-6. PubMed ID: 9043561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model.
    Nesbit TW; Shermock KM; Bobek MB; Capozzi DL; Flores PA; Leonard MC; Long JK; Militello MA; White DA; Barone LD; Goldman MP; Kvancz DA
    Am J Health Syst Pharm; 2001 May; 58(9):784-90. PubMed ID: 11351918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
    Hamblin S; Rumbaugh K; Miller R
    J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
    Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
    J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
    Kopp BJ; Mrsan M; Erstad BL; Duby JJ
    Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pharmacist interventions on cost avoidance in an ambulatory cancer center.
    Randolph LA; Walker CK; Nguyen AT; Zachariah SR
    J Oncol Pharm Pract; 2018 Jan; 24(1):3-8. PubMed ID: 27682600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand.
    Sukkha S; Rattanavipanon W; Chamroenwit B; Sanganurak M; Nathisuwan S; Chaikledkaew U; Kongwatcharapong J
    Int J Clin Pharm; 2020 Apr; 42(2):610-616. PubMed ID: 32221826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
    de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
    J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing comprehensive pharmaceutical services at an academic tertiary care hospital.
    Janning SW; Stevenson JG; Smolarek RT
    Am J Health Syst Pharm; 1996 Mar; 53(5):542-7. PubMed ID: 8697014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy.
    Lankford C; Dura J; Tran A; Lam SW; Naelitz B; Willner M; Geyer K
    J Manag Care Spec Pharm; 2021 Mar; 27(3):379-384. PubMed ID: 33645240
    [No Abstract]   [Full Text] [Related]  

  • 12. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
    Muñoz-Pichuante D; Villa-Zapata L
    J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital.
    Zaidi ST; Hassan Y; Postma MJ; Ng SH
    Pharm World Sci; 2003 Dec; 25(6):299-302. PubMed ID: 14689820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of pharmacist interventions.
    Torchinsky A; Landry D
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
    Chan LEJ; Soong JL; Lie SA
    Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of the impact of a critical care pharmacist assigned as a member of the multidisciplinary burn care team.
    Patel NP; Brandt CP; Yowler CJ
    J Burn Care Res; 2006; 27(3):310-3. PubMed ID: 16679898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Documentation of pharmacists' interventions in an emergency department and associated cost avoidance.
    Lada P; Delgado G
    Am J Health Syst Pharm; 2007 Jan; 64(1):63-8. PubMed ID: 17189582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals.
    Dooley MJ; Allen KM; Doecke CJ; Galbraith KJ; Taylor GR; Bright J; Carey DL
    Br J Clin Pharmacol; 2004 Apr; 57(4):513-21. PubMed ID: 15025751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
    Saokaew S; Maphanta S; Thangsomboon P
    Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
    Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
    J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.